search
Back to results

Assessing Open Access Audio (OAA)

Primary Purpose

Hypertension, Diabetes

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Open Access Audio
No Access, Patient and Provider Aware of Recording
No Access, Provider Unaware of Recording
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Hypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • All patients with scheduled appointments at the participating sites: primary care and diabetes clinics at Jesse Brown VA Medical Center and the Louis Stokes Cleveland VA Medical Center

Exclusion Criteria:

  • None

Sites / Locations

  • Jesse Brown VA Medical Center, Chicago, ILRecruiting
  • Louis Stokes VA Medical Center, Cleveland, OH

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Sham Comparator

Placebo Comparator

Arm Label

OAA Intervention

OAA Physician Aware Control

OAA Physician Unaware Control

Arm Description

Visit recorded, both patient and provider aware, both patient and provider have access to audio post-visit

Visit recorded, both patient and provider aware, neither patient nor provider have access to audio post-visit

Visit recorded, patient aware but provider unaware, neither patient nor provider have access to audio post-visit

Outcomes

Primary Outcome Measures

Blood pressure
This outcome tests the hypothesis that blood pressure control improves in patients with blood pressure > 140/90 when they have access to an audio recording of their visit with their provider regarding blood pressure management compared to those who do not. An improvement in blood pressure is defined as a reduction of 10 or more mmHg in either the systolic or diastolic blood pressure.
Glycosylated Hemoglobin (HgB A1c)
This outcome tests the hypothesis that HgB A1c improves in patients with Hgb A1c > 7 when they have access to an audio recording of their discussion with their provider regarding diabetes management compared to when they do no. An improvement is defined as a decrease of 1% or more.
Return Visit Adherence (RVA)
This outcome tests the hypothesis that return visit adherence (RVA) improves in patients with non-adherence when they have access to an audio recording of their discussion with their provider. RVA is the percentage of all scheduled visits to any clinics at the facility that the patient attends. Non-adherence is defined as an RVA < 80% during the 6 months prior to the audio recorded visit. A reduction in the RVA of 10% or more is an improved outcome.
Prescription Refill Rate (PDC -- Proportion of Days Covered)
This outcome tests the hypothesis that PDC improves in patients with non-adherence when they have access to an audio recording of their discussion with their provider compared to when they do not. PDC is the total number of days covered by refills in a measurement period divided by the number of days between the first fill and the end of the measurement period. Non-adherence is defined as a PDC<80% during the 6 months prior to the audio recorded visit. An improved outcome is defined as a 10% or greater improvement post visit in any patient classified as non-adherent pre-visit.
Patient Activation Measure (PAM)
This outcome tests the hypothesis that patient activation is higher in patients when they have access to an audio recording of their visit with their provider compared to when they do not. Patients are called by phone post visit to answer PAM 10, a 10 item questionnaire with a 5 point Likert response that scores their perceived knowledge, skills, and confident in their capacity to follow their treatment plan with scores from 0-100. A higher score indicates higher patient activation.
SEGUE Framework for evaluating and scoring communication behavior.
This outcome tests the hypothesis that physicians communicate more effectively when they are aware the visit is being recorded for the patient to when they are not. Communication behavior will be rated off the audio recording by a research assistant utilizing the SEGUE checklist. Outcome measure is total score on 32 item SEGUE instrument with a higher score indicating more effective communication.
Contextualization of Care
This outcome tests the hypothesis that physicians are more likely to contextualize the care plan when they are aware the visit is being recorded for the patient to when they are not. Contextualization of care will be rated off of the audio recording by a research assistant trained in Content Coding for Contextualization of Care (4C Coding). Outcome measure is the percentage of encounters in which the care plan was coded as contextualized.

Secondary Outcome Measures

Emergency department utilization
This outcome tests the hypothesis that emergency department visit rates are lower following encounters in which patients have access to an audio recording of their visit with their provider compared to when they do not. Outcome measure is the average number of ED visits during the designated (6 month) time period following the audio recorded visit.
hospital admission rate
This outcome tests the hypothesis that inpatient admission rates are lower following encounters in which patients have access to an audio recording of their visit with their provider compared to when they do not. Outcome measure is the average number of inpatient admissions during the designated (6 month) time period following the audio recorded visit.

Full Information

First Posted
June 25, 2020
Last Updated
September 19, 2023
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT04452331
Brief Title
Assessing Open Access Audio
Acronym
OAA
Official Title
An Assessment of Open Access Audio of the Clinical Encounter on Veterans and Their Care
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 5, 2021 (Actual)
Primary Completion Date
July 31, 2024 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The medical encounter can be overwhelming in term of the amount of information discussed, its technical nature, and the anxiety it can generate. Easy access to a secure audio recording from any internet enabled device is an available low cost technology that allows patients to "revisit the visit" either alone or sharing with caretakers and family. It has been introduced and tested outside the VA with evidence that it increases patient recall and understanding and may even improve physician performance. Little is known, however, about whether and to what extent these effects lead to better outcomes, such as improved treatment plan adherence and chronic disease self-management. This study is a randomized controlled trial designed ascertain whether easy access to audio recordings of the medical visit improves patients perception that they understand and can manage their own care, and leads to a variety of improved outcomes, such as better blood pressure and diabetes control, and fewer emergency department visits and hospitalizations.
Detailed Description
The study aims to assess (1) the impact of an open access audio (OAA) program on two behaviors (patient activation, treatment plan adherence), and two chronic condition measures (glycosylated hemoglobin, blood pressure); (2) the impact of open access audio on provider communication and on their attention to patient contextual factors (i.e. individual Veteran's needs and circumstances relevant to planning effective care); and (3) patient, provider, and leadership perceptions of the extent to which the program is safe, not burdensome, and worthwhile at both the start and at two years into the program. A secondary analysis will descriptively measure the effect size of OAA on ED visits and hospital admissions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Diabetes

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The setting will be primary care and diabetes clinics, at two facilities for generalizability. To achieve aims 1 and 2, the investigators plan a randomized controlled three arm design: (1) the encounter is recorded, with provider and patient aware, and uploaded to a server the Veteran, provider, and research team can access post visit; (2) the encounter is recorded, with both parties aware, and uploaded to a server only the research team can access; and (3) the encounter is recorded, with only the patient aware, and uploaded to a server only the research team can access. Resource utilization and disease measures indicated in aims 1 and 2 will be collected in all arms.
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Arm 1 is the intervention, with both provider and patient aware of the recording. It is designed to represent how OAA would be utilized in actual practice. In Arm 2 all parties are also aware of the audio recording, but this time neither gets access to the audio after the visit (although the research team does). Arm 2 is a control for isolating the effect of patient access after the visit to the audio in Arm 1. Both patient and physician are blind to whether they are in Arm 1 or 2 until after the visit. Arm 3 is a second kind of control, as the audio is again not shared with the patient. In this arm, however, the patient conceals the audio recorder, so that the provider is unaware they are being audio recorded until after the visit.
Allocation
Randomized
Enrollment
2308 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
OAA Intervention
Arm Type
Experimental
Arm Description
Visit recorded, both patient and provider aware, both patient and provider have access to audio post-visit
Arm Title
OAA Physician Aware Control
Arm Type
Sham Comparator
Arm Description
Visit recorded, both patient and provider aware, neither patient nor provider have access to audio post-visit
Arm Title
OAA Physician Unaware Control
Arm Type
Placebo Comparator
Arm Description
Visit recorded, patient aware but provider unaware, neither patient nor provider have access to audio post-visit
Intervention Type
Other
Intervention Name(s)
Open Access Audio
Other Intervention Name(s)
OAA
Intervention Description
Patient obtains secure access to an audio recording of the medical encounter post-visit that is accessible from any internet enabled device.
Intervention Type
Other
Intervention Name(s)
No Access, Patient and Provider Aware of Recording
Other Intervention Name(s)
OAA All Aware
Intervention Description
Patient does not obtain access to audio recording but both patient and provider are aware visit is being recorded.
Intervention Type
Other
Intervention Name(s)
No Access, Provider Unaware of Recording
Other Intervention Name(s)
OAA Provider Unaware
Intervention Description
Patient does not obtain access to audio recording and provider is unaware visit is being recorded.
Primary Outcome Measure Information:
Title
Blood pressure
Description
This outcome tests the hypothesis that blood pressure control improves in patients with blood pressure > 140/90 when they have access to an audio recording of their visit with their provider regarding blood pressure management compared to those who do not. An improvement in blood pressure is defined as a reduction of 10 or more mmHg in either the systolic or diastolic blood pressure.
Time Frame
6 months
Title
Glycosylated Hemoglobin (HgB A1c)
Description
This outcome tests the hypothesis that HgB A1c improves in patients with Hgb A1c > 7 when they have access to an audio recording of their discussion with their provider regarding diabetes management compared to when they do no. An improvement is defined as a decrease of 1% or more.
Time Frame
4-6 months
Title
Return Visit Adherence (RVA)
Description
This outcome tests the hypothesis that return visit adherence (RVA) improves in patients with non-adherence when they have access to an audio recording of their discussion with their provider. RVA is the percentage of all scheduled visits to any clinics at the facility that the patient attends. Non-adherence is defined as an RVA < 80% during the 6 months prior to the audio recorded visit. A reduction in the RVA of 10% or more is an improved outcome.
Time Frame
6 months
Title
Prescription Refill Rate (PDC -- Proportion of Days Covered)
Description
This outcome tests the hypothesis that PDC improves in patients with non-adherence when they have access to an audio recording of their discussion with their provider compared to when they do not. PDC is the total number of days covered by refills in a measurement period divided by the number of days between the first fill and the end of the measurement period. Non-adherence is defined as a PDC<80% during the 6 months prior to the audio recorded visit. An improved outcome is defined as a 10% or greater improvement post visit in any patient classified as non-adherent pre-visit.
Time Frame
6 months
Title
Patient Activation Measure (PAM)
Description
This outcome tests the hypothesis that patient activation is higher in patients when they have access to an audio recording of their visit with their provider compared to when they do not. Patients are called by phone post visit to answer PAM 10, a 10 item questionnaire with a 5 point Likert response that scores their perceived knowledge, skills, and confident in their capacity to follow their treatment plan with scores from 0-100. A higher score indicates higher patient activation.
Time Frame
2 weeks
Title
SEGUE Framework for evaluating and scoring communication behavior.
Description
This outcome tests the hypothesis that physicians communicate more effectively when they are aware the visit is being recorded for the patient to when they are not. Communication behavior will be rated off the audio recording by a research assistant utilizing the SEGUE checklist. Outcome measure is total score on 32 item SEGUE instrument with a higher score indicating more effective communication.
Time Frame
2 weeks
Title
Contextualization of Care
Description
This outcome tests the hypothesis that physicians are more likely to contextualize the care plan when they are aware the visit is being recorded for the patient to when they are not. Contextualization of care will be rated off of the audio recording by a research assistant trained in Content Coding for Contextualization of Care (4C Coding). Outcome measure is the percentage of encounters in which the care plan was coded as contextualized.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Emergency department utilization
Description
This outcome tests the hypothesis that emergency department visit rates are lower following encounters in which patients have access to an audio recording of their visit with their provider compared to when they do not. Outcome measure is the average number of ED visits during the designated (6 month) time period following the audio recorded visit.
Time Frame
6 months
Title
hospital admission rate
Description
This outcome tests the hypothesis that inpatient admission rates are lower following encounters in which patients have access to an audio recording of their visit with their provider compared to when they do not. Outcome measure is the average number of inpatient admissions during the designated (6 month) time period following the audio recorded visit.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All patients with scheduled appointments at the participating sites: primary care and diabetes clinics at Jesse Brown VA Medical Center and the Louis Stokes Cleveland VA Medical Center Exclusion Criteria: None
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Saul J Weiner, MD
Phone
(312) 413-2799
Email
saul.weiner@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Gunjan S Sharma, PhD
Phone
(312) 569-6486
Email
Gunjan.Sharma2@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Saul J. Weiner, MD
Organizational Affiliation
Jesse Brown VA Medical Center, Chicago, IL
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jesse Brown VA Medical Center, Chicago, IL
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karen M Lenehan
Phone
312-569-6343
Email
Karen.Lenehan@va.gov
First Name & Middle Initial & Last Name & Degree
Saul J. Weiner, MD
Facility Name
Louis Stokes VA Medical Center, Cleveland, OH
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106-1702
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Corinna D Falck-Ytter, MD
Email
Corinna.Falck-Ytter@va.gov
First Name & Middle Initial & Last Name & Degree
Sherry L Ball, PhD
Phone
(216) 791-2300
Ext
5830
Email
sherry.ball@va.gov
First Name & Middle Initial & Last Name & Degree
Corinna D. Falck-Ytter, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Assessing Open Access Audio

We'll reach out to this number within 24 hrs